Arthex Biotech Appoints Frédéric Legros, Ph.D., as Executive Chairman of the Board

VALENCIA, Spain, Nov. 28, 2022 /PRNewswire/ -- Arthex Biotech S.A., a pre-clinical stage biotechnology company pioneering innovative microRNA modulating approaches to diseases with high unmet medical needs, today announced that Frédéric Legros, PhD, has joined the Company's Board of...

Click to view original post